Phenotypic analysis of epilepsy in the mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes-associated mitochondrial DNA A3243G mutation

Journal of Child Neurology

Volumn 29, Issue 9, 2014, Pages 1249-1256

  Demarest, Scott T ^a   Whitehead, Matthew T ^a   Turnacioglu, Sinan ^a   Pearl, Phillip L ^b   Gropman, Andrea L ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Electroencephalogram; Lennox Gastaut syndrome; Mitochondria; Seizures

Indexed keywords

ETHOSUXIMIDE; MITOCHONDRIAL DNA;

ADOLESCENT; ADULT; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA POLYMORPHISM; ELECTROGRAPHY; EPILEPSY; EPILEPTIC DISCHARGE; EPILEPTIC STATE; FEMALE; FOCAL EPILEPSY; HUMAN; LENNOX GASTAUT SYNDROME; MELAS SYNDROME; PHENOTYPIC VARIATION; POINT MUTATION; PRIORITY JOURNAL; SCHOOL CHILD; SPIKE WAVE; YOUNG ADULT; BRAIN; CASE REPORT; ELECTROENCEPHALOGRAPHY; GENETICS; MALE; PATHOPHYSIOLOGY; PHENOTYPE; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; BRAIN; CHILD; DNA, MITOCHONDRIAL; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; MALE; MELAS SYNDROME; PHENOTYPE; POINT MUTATION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84927714204     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073814538511     Document Type: Conference Paper

References (24)

1. Kaufman KR, Zuber N, Rueda-Lara MA, Tobia A. MELAS with recurrent complex partial seizures, nonconvulsive status epilepticus, psychosis, and behavioral disturbances: case analysis with literature review. Epilepsy Behav. 2010;18:494-497.
2. Koga Y, Povalko N, Nishioka J, et al. Molecular pathology of MELAS and L-arginine effects. Biochim Biophys Acta. 2012; 1820:608-614.
3. Uusimaa J, Moilanen JS, Vainionpaa L, et al. Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children. Ann Neurol. 2007;62:278-287.
4. Pavlakis SG, Phillips PC, DiMauro S, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol. 1984;16:481-488.
5. Corda D, Rosati G, Deiana GA, Sechi G. "Erratic" complex partial status epilepticus as a presenting feature of MELAS. Epilepsy Behav. 2006;8:655-658.
6. Karkare S, Merchant S, Solomon G, et al. MELAS with A3243G mutation presentingwith occipital status epilepticus.JChildNeurol. 2009;24:1564-1567.
7. Lin CM, Thajeb P. Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA. Metab Brain Dis. 2007;22:105-109.
8. Oguro H, Iijima K, Takahashi K, et al. Successful treatment with succinate in a patient with MELAS. Intern Med. 2004;43:427-431.
9. Canafoglia L, Franceschetti S, Antozzi C, et al. Epileptic phenotypes associated with mitochondrial disorders. Neurology. 2001; 56:1340-1346.
10. Funakawa I, Yasuda T, Terao A. Periodic lateralized epileptiform discharges in mitochondrial encephalomyopathy. Electroencephalogr Clin Neurophysiol. 1997;103:370-375.
11. Kanaumi T, Hirose S, Goto Y, et al. An infant with a mitochondrial A3243G mutation demonstrating the MELAS phenotype. Pediatr Neurol. 2006;34:235-238.
12. Leff AP, McNabb AW, Hanna MG, et al. Complex partial status epilepticus in late-onset MELAS. Epilepsia. 1998;39:438-441.
13. Ribacoba R, Salas-Puig J, Gonzalez C, Astudillo A. Characteristics of status epilepticus in MELAS. Analysis of four cases. Neurologia. 2006;21:1-11.
14. Kim IO, Kim JH, Kim WS, et al. Mitochondrial myopathyencephalopathy-lactic acidosis-and strokelike episodes (MELAS) syndrome: CT and MR findings in seven children. AJR Am J Roentgenol. 1996;166:641-645.
15. Toribe Y, Tominaga K, Ogawa K, Suzuki Y. Usefulness of L-arginine infusion for status epilepticus in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. No To Hattatsu. 2007;39:38-43.
16. Lee YM, Kang HC, Lee JS, et al. Mitochondrial respiratory chain defects: underlying etiology in various epileptic conditions. Epilepsia. 2008;49:685-690.
17. Yuen AW, Sander JW. Impaired mitochondrial energy production: the basis of pharmacoresistance in epilepsy. Med Hypotheses. 2011;77:536-540.
18. Tzoulis C, Bindoff LA. Acute mitochondrial encephalopathy reflects neuronal energy failure irrespective of which genome the genetic defect affects. Brain. 2012;135(pt 12):3627-3634.
19. Kang HC, Lee YM, Kim HD. Mitochondrial disease and epilepsy. Brain Dev. 2013;35:757-761.
20. Koga Y, Ishibashi M, Ueki I, et al. Effects of L-arginine on the acute phase of strokes in three patients with MELAS. Neurology. 2002;58:827-828.
21. Koga Y, Akita Y, Nishioka J, et al. L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology. 2005;64: 710-712.
22. Bolszak M, Anttonen AK, Komukainen T, et al. Digenic mutations in severe myoclonic epilepsy of infancy. Epilepsy Res. 2009;85:300-304.
23. Craig AK, de Menezes MS, Saneto RP. Dravet syndrome: patients with co-morbid SCN1A gene mutations and mitochondrial electron transport chain defects. Seizure. 2012;21:17-20.
24. Anglin RE, Tarnopolsky MA, Mazurek MF, Rosebush PI. The psychiatric presentation of mitochondrial disorders in adults. J Neuropsychiatry Clin Neurosci. 2012;24:394-409.